ロード中...
Molecular Mechanisms of Trastuzumab Resistance in HER2 Overexpressing Breast Cancer
The epidermal growth factor receptor 2 (HER2) is a tyrosine kinase overexpressed in nearly 20% to 25% of invasive breast cancers. Trastuzumab is a humanized monoclonal antibody that targets HER2. The majority of patients with metastatic breast cancer initially respond to trastuzumab, however, within...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE-Hindawi Access to Research
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3262573/ https://ncbi.nlm.nih.gov/pubmed/22295219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4061/2011/352182 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|